Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole prophylaxis for prevention of influenza-associated aspergillosis in critically ill ICU patients with severe influenza
NL-OMON46362Phase 4Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in aspergillosis comparing Posaconazole prophylaxis + standard of care with Standard of care (2 arms). Primary endpoint: Incidence of influenza-associated aspergillosis at ICU discharge. Started Feb 2018; status: recruiting.
02
Drugs
posaconazole
03
Conditions
aspergillosis
Beyond the preview
Go deeper on NL-OMON46362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46362.